LeMaitre Vascular
LMAT
42 hedge funds and large institutions have $61.5M invested in LeMaitre Vascular in 2014 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 18 increasing their positions, 12 reducing their positions, and 5 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 12
24% more capital invested
Capital invested by funds: $49.5M → $61.5M (+$12.1M)
5% less funds holding
Funds holding: 44 → 42 (-2)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Top Buyers
| 1 |
AWMDMG
Austin W. Marxe & David M. Greenhouse
New York
|
+$7.82M |
| 2 |
Millennium Management
New York
|
+$1.54M |
| 3 |
CC
Cannell Capital
Alta,
Wyoming
|
+$782K |
| 4 |
SC
Skylands Capital
Milwaukee,
Wisconsin
|
+$411K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$331K |
Top Sellers
LMAT Hedge Fund Activity: Q2 2014 in Review
42 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q2 2014, worth a combined $61.5M — up 24% from $49.5M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of LMAT and 3 opened new positions — a net loss of 2 holders — while 12 trimmed existing stakes and 18 added.
The largest buyer was Austin W. Marxe & David M. Greenhouse, adding an estimated $7.82M. The largest seller was Wellington Management Group, cutting an estimated $464K.
- 42 institutional investors held LeMaitre Vascular (LMAT) as of Q2 2014, down from 44 in Q1 2014.
- Funds reported $61.5M of LeMaitre Vascular stock for Q2 2014, up 24% quarter-over-quarter.
- 3 funds opened new LeMaitre Vascular positions in Q2 2014 and 5 closed out, a net change of -2 holders.
- The largest LeMaitre Vascular buyer in Q2 2014 was Austin W. Marxe & David M. Greenhouse, an estimated $7.82M added.
- The largest LeMaitre Vascular seller in Q2 2014 was Wellington Management Group, an estimated $464K sold.
Based on aggregated 13F filings for Q2 2014.